As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug

As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug

Source: 
Endpoints
snippet: 

British drugmaker Indivior got the green light from US regulators to sell its schizophrenia drug Perseris — a relief, no doubt, considering the company’s ongoing exclusivity war over its staple drug Suboxone.